Drug & Device Safety Atlas

FDA recall record · openFDA

Biomerieux Inc

4 FDA recalls on record (2023–2026) — 4 device. 4 still ongoing.

1
Class I (most serious)
3
Class II
0
Class III
4
ongoing

How to read this. A recall count is not a quality verdict — large manufacturers recall more simply by volume, and a voluntary recall is the safety system working as intended. The signal to weight is the Class I count (the FDA's most-serious tier — reasonable probability of serious harm or death) and whether recalls are still ongoing. Most recalls are Class II/III. "Ongoing" reflects openFDA's last-published status — device recalls often stay marked ongoing long after they're resolved in practice; confirm current status at the FDA.

Most common reasons

Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobact 1
Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the 1
Potential for false resistant results for Colistin (cs02n) with multi-drug-resistant Pseudomonas aeruginosa and Acinetob 1
For users with MYLA V4.8.X / V4.9 that use VITEK MS to identify organisms as part of their workflow, AST filter rules th 1

Recalls

RECORDED — these are the FDA's published recall enforcement records (openFDA). Recalls are listed under the exact firm name as filed; a large manufacturer may also file under name variants, so this may not be the company's complete cross-variant record — confirm at the FDA recall database. This page informs and routes; it is not medical advice or a verdict on the company.

Machine-readable: JSON-LD · Markdown